Tan EM, Schur PH, Carr PI, Kunkel HGDeoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest1966; 45: 1732-8.
2.
Roosnek E., Lanzaveccia A.Efficeint and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med1991 ; 173: 487-9.
3.
Tighe H., Chen PP, Tucker R., Kipps TJ, Roudier J., Jirik FR, Cardon DAFunction of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice. J Exp Med1993; 177: 109-18.
4.
Dighiero G., Lymberi P., Holmberg D., Lundquist I., Coutinho A., Avrameas S.High frequency of natural autoantibodies in normal newborn mice. J Immunol1985; 134: 765-71.
5.
Coutinho A., Freitas AA@#x3C; Homberg D., Grandien A.Expression and seelction of murine antibody repertoires. Intern Rev Immunol1992; 8: 173-97.
6.
Schlomchik MJ , Mascelli M., Shan H., Radic MZ, Pisetsky D., Marshak-Rothstein A., Weigert MGAnti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med1990; 171: 265-70.
7.
Tillman DM, Nainn-Tsyr J., Hill RJ, Marion TNBoth IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB × NZW)F1 mice. J Exp Med1992; 176: 761-79.
8.
VanEs JH, Gmelig Meyling FH, van de Akker MR, Aanstoot H, Derksen RH, Logtenberg T. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus. J Exp Med1991; 173: 461-70.
9.
Winkler TH, Fehr H., Kalden JRAnalysis of immunoglobulin variable region genes from IgG anti-DNA hybridomas . Eur J Immunol1992; 22: 1719-28.
10.
Wofsy D., Seaman WESuccessful treatment of autoimmunity in (NZB/NZW) F1 mice with monoclonal antibody to L3T4. J Exp Med1985 ; 161: 378-91.
11.
Connolly K. , Roubinina JR@#x3C; Wofsy D.Development of muruine lupus in CD4-depleted NZB/NZB mice. J Immunol1992; 149: 3083-88.
12.
Anod DG, Sercarz EE, Hahn BHMechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol1987; 138: 3185-90.
13.
Shivakumar S., Tsokos GC, Datta SKT cell receptor alpha/beta expressing double negative (CD4-/CD8-) and CD4 + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol1989; 143: 103-12.
14.
Naiki M., Chiang BL, Cawley D., Ansari A., Rozzo SJ, Kotzin BL, Zlotnik A., Gershwin MEGeneration and characterization of cloned helper T cell lines for anti-DNA responses in NZB.H-2bm12 mice. J Immunol1992 , 149: 4109-15.
15.
Mohan C., Adams S., Stanik V., Datta SKNucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med1993; 177: 1367-81.
16.
Klinman DMPolyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J Clin Invest1990; 86: 1249-52.
17.
Reiniuger L. , Radaszkiewicz T., Kosco M., Melchers F., Rolink AGDevleopment of autoimmune disease in SCID mice populated with long-term in vitro proliferating (NZB X NZW) F1 pre-B cells. J Exp Med1992; 176: 1343-53.
18.
Merino R., Iwamoto M., Fossati L., Izui S.Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB X NZW)F1 and NRL/MpJ-lpr/lpr mice. J Immunol1993; 151: 6509-16.
19.
Lewkonia RMThe clinical genetics of lupus. Lupus1992; 1: 55-62.
